hepatic encephalopathy/nàusea

L'enllaç es desa al porta-retalls

Trieu el tipus d'ordenació

Pàgina 1 des de 37 resultats

Disabling portosystemic encephalopathy in a non-cirrhotic patient: Successful endovascular treatment of a giant inferior mesenteric-caval shunt via the left internal iliac vein.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Hepatic encephalopathy is suspected in non-cirrhotic cases of encephalopathy because the symptoms are accompanied by hyperammonaemia. Some cases have been misdiagnosed as psychiatric diseases and consequently patients hospitalized in psychiatric institutions or geriatric facilities. Therefore, the

Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Lactulose is currently the drug of choice for the treatment of hepatic encephalopathy. It is, however, only available as a syrup which is contaminated with other sugars. Consequently patients may express aversion to its excessively sweet taste and many experience nausea because of its

Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

The effect of lactitol, a new non-absorbable disaccharide, in the treatment of chronic hepatic encephalopathy was assessed in 14 cirrhotic patients with non-selective portosystemic anastomosis in a randomized, cross-over study. At the time of inclusion, all patients showed alterations in mental

Branched-chain amino acids for people with hepatic encephalopathy.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Hepatic encephalopathy is a brain dysfunction with neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting. The severity ranges from minor symptoms to coma. A Cochrane systematic review including 11 randomised clinical trials on branched-chain

A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed. OBJECTIVE To make a diagnosis of HE, we explored the value of ammonia

Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. A double-blind controlled trial.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

A double-blind comparison of metoclopramide versus placebo was performed on 8 cirrhotic patients with nausea (8 cases) and heartburn (3 of the 8 cases) plus mild portal-systemic encephalopathy. As metoclopramide is a dopamine antagonist and dopamine-inadequate neurotransmission has been implicated

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Phenylacetic acid (PAA) is the active moiety in sodium phenylbutyrate (NaPBA) and glycerol phenylbutyrate (GPB, HPN-100). Both are approved for treatment of urea cycle disorders (UCDs) - rare genetic disorders characterized by hyperammonemia. PAA is conjugated with glutamine in the liver

Branched-chain amino acids for people with hepatic encephalopathy.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Branched-chain amino acids for people with hepatic encephalopathy.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Hepatic encephalopathy is a brain dysfunction with neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting. The severity ranges from minor symptoms to coma. A Cochrane systematic review including 11 randomised clinical trials on branched-chain amino acids

Typhoid, hepatitis E, or typhoid and hepatitis E: the cause of fulminant hepatic failure--a diagnostic dilemma.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

OBJECTIVE To report a case of hepatitis E-induced fulminant hepatic failure associated with typhoid fever, diagnosed with the Widal test. METHODS Case report. METHODS Eight-bed medical/surgical intensive care unit of a university hospital. METHODS A 15-yr-old, 50-kg male with grade IV hepatic

[Fever and liver cirrhosis].

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Occurrence of fever in a patient with liver cirrhosis should suggest the following: 1. Endotoxemia. Endotoxins are normally present in portal blood; in hepatic cirrhosis they are insufficiently cleared by the liver and their presence can be demonstrated in the systemic circulation by the "limulus

Retrospective study of seven cases with acute Fatty liver of pregnancy.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Objectives. Our aim is to explore the clinical outcome of patients with acute fatty liver of pregnancy (AFLP), and evaluate the effect of early diagnosis and treatment. Methods. Seven patients who were diagnosed with AFLP were retrospectively analyzed from February 2005 to January 2013. The clinical

Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Introduction Hepatitis C virus (HCV) is the leading cause of cirrhosis. The advent of Directly Acting Antivirals (DAAs) like Sofosbuvir (SOF) has dramatized the treatment and is the cornerstone for the treatment of HCV. Most trials have been conducted in HCV genotype 1 (GT-1) and data for

Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Pain management in cirrhosis is a clinical challenge. Most analgesics are metabolized in the liver and cirrhosis may deeply alter their concentration, favouring the appearance of side effects. We aimed to assess the efficacy and safety of oral prolonged-release association of oxycodone/naloxone

Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short- and long-term exposure.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Alpha-methyldopa-induced histologic alterations were investigated in 21 patients with hepatic injury after short- and long-term exposure. Seven patients developed liver injury within 6 months and 24 after several years (mean, 5 years) of exposure. Histologic findings and clinical and biochemical

Anterior
1
2
3
Pròxim

Uneix-te a la nostra
pàgina de Facebook

Herbal & Natural Medicine

La base de dades d’herbes medicinals més completa avalada per la ciència

Funciona en 55 idiomes
Cures a base d'herbes recolzades per la ciència
Reconeixement d’herbes per imatge
Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
Llegiu publicacions científiques relacionades amb la vostra cerca
Cerqueu herbes medicinals pels seus efectes
Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades